Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biochemistry (Mosc) ; 88(12): 2094-2106, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38462453

RESUMO

Neutrophils play a dual role in protecting the body. They are able to penetrate infected tissues and destroy pathogens there by releasing aggressive bactericidal substances. While into the surrounding tissues, the aggressive products secreted by neutrophils initiate development of inflammatory processes. Invasion of neutrophils into tissues is observed during the development of pneumonia in the patients with lung diseases of various etiologies, including acute respiratory distress syndrome caused by coronavirus disease. Synthetic corticosteroid hormone dexamethasone has a therapeutic effect in treatment of lung diseases, including reducing mortality in the patients with severe COVID-19. The acute (short-term) effect of dexamethasone on neutrophil adhesion to fibrinogen and concomitant secretion was studied. Dexamethasone did not affect either attachment of neutrophils to the substrate or their morphology. Production of reactive oxygen species (ROS) and nitric oxide (NO) by neutrophils during adhesion also did not change in the presence of dexamethasone. Dexamethasone stimulated release of metalloproteinases in addition to the proteins secreted by neutrophils during adhesion under control conditions, and selectively stimulated release of free amino acid hydroxylysine, a product of lysyl hydroxylase. Metalloproteinases play a key role and closely interact with lysyl hydroxylase in the processes of modification of the extracellular matrix. Therapeutic effect of dexamethasone could be associated with its ability to reorganize extracellular matrix in the tissues by changing composition of the neutrophil secretions, which could result in the improved gas exchange in the patients with severe lung diseases.


Assuntos
Pneumopatias , Neutrófilos , Humanos , Pró-Colágeno-Lisina 2-Oxoglutarato 5-Dioxigenase/metabolismo , Pró-Colágeno-Lisina 2-Oxoglutarato 5-Dioxigenase/farmacologia , Dexametasona/farmacologia , Dexametasona/metabolismo , Metaloproteases/metabolismo , Metaloproteases/farmacologia , Pneumopatias/metabolismo
2.
J Cereb Blood Flow Metab ; 39(3): 547-561, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30516406

RESUMO

Hypertensive intracerebral hemorrhage (ICH) is a devastating cerebrovascular disease with no effective treatment. Lysyl hydroxylase 3 (LH3) is essential for collagen IV intermolecular crosslinking and stabilization. Deficiency in LH3 affects the assembly and secretion of collagen IV and basement membrane (BM) integrity of vessels. Here, we investigated whether LH3 has significant implications for disease progression and therapeutic intervention. Spontaneous hypertensive ICH of mice was induced by angiotensin II and L-NAME treatment. The adeno-associated virus was delivered into brain by stereotactic injection to knockdown or overexpress LH3. We found LH3 levels were reduced in human patients with ICH and gradually decreased in mice before ICH. LH3 knockdown increased the incidence of hypertensive ICH in mice. The incidence, number, and size of ICHs in mice were markedly reduced by LH3 overexpression. RNA-seq revealed that LH3 overexpression significantly reversed the profound alterations in gene transcriptional profiles of cerebral vessels. LH3 overexpression was sufficient to enhance BM integrity, inhibit matrix metalloproteinase activity, attenuate microglial activation and leukocyte infiltration, and reduce VSMC apoptosis before ICH. These results indicate that LH3 overexpression attenuates susceptibility to hypertensive ICH. We emphasize that LH3 modulation may serve as a viable approach for future investigations of ICH prevention.


Assuntos
Hemorragia Intracraniana Hipertensiva/prevenção & controle , Pró-Colágeno-Lisina 2-Oxoglutarato 5-Dioxigenase/metabolismo , Animais , Membrana Basal/irrigação sanguínea , Vasos Sanguíneos/efeitos dos fármacos , Progressão da Doença , Suscetibilidade a Doenças , Humanos , Incidência , Hemorragia Intracraniana Hipertensiva/induzido quimicamente , Hemorragia Intracraniana Hipertensiva/tratamento farmacológico , Camundongos , Pró-Colágeno-Lisina 2-Oxoglutarato 5-Dioxigenase/administração & dosagem , Pró-Colágeno-Lisina 2-Oxoglutarato 5-Dioxigenase/farmacologia
3.
Am J Med Genet A ; 124A(1): 28-34, 2004 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-14679583

RESUMO

The brittle cornea syndrome (BCS) is a generalized connective tissue disorder characterized by corneal rupture following only minor trauma, keratoconus or keratoglobus, blue sclerae, hyperelasticity of the skin without excessive fragility, and hypermobility of the joints. It is inherited as an autosomal recessive trait but the underlying genetic defect remains undetermined. We present 23 patients (11 male) from 13 nuclear families followed at the King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, aged 3-28 years at last follow-up. A total of 28 events of corneal rupture were noted in 17 patients (eight male), among whom nine had had bilateral ruptures, and eight had had unilateral ruptures (four of the right cornea), while two had experienced re-rupture 2 and 4 years, respectively, after surgery; six patients (aged 3-21 years) had had no ruptures. We describe the natural history of our cases and discuss them together with those others reported in the literature. Because of similarities between the BCS and the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VI), both disorders tend to have been confounded. Here, we show that all of our BCS patients tested in this regard had biochemical findings reflective of normal activity of lysyl hydroxylase, characteristically deficient in EDS VI, such as normal urinary total pyridinoline ratios and/or normal electrophoretic migration of collagen chains produced by dermal fibroblasts. The BCS is, therefore, an entity distinct from the kyphoscoliotic type of EDS, which has a much poorer prognosis.


Assuntos
Doenças da Córnea/diagnóstico , Doenças da Córnea/genética , Síndrome de Ehlers-Danlos/diagnóstico , Pró-Colágeno-Lisina 2-Oxoglutarato 5-Dioxigenase/farmacologia , Adolescente , Adulto , Criança , Pré-Escolar , Diagnóstico Diferencial , Síndrome de Ehlers-Danlos/genética , Feminino , Humanos , Masculino , Linhagem , Pró-Colágeno-Lisina 2-Oxoglutarato 5-Dioxigenase/análise , Ruptura Espontânea , Síndrome
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...